ImmuCell Share Price

ImmuCell Share Price

NASDAQ: ICCC | Healthcare
$0.00
-$11.43 (--%)
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • About
  • Price history
  • FAQs

ImmuCell Stock Performance

Open
N/A
Prev. Close
$11.43
Circuit Range
N/A
Day Range
N/A
Year Range
$4.60 - $11.93
Volume
N/A
Average Traded
N/A

ImmuCell Share Price Chart

Line chart of the ImmuCell price trend over the selected period. The price fell overall, ranging from 11.27 to 11.46, ending at 11.29.
$0.00$0.00
L
Show Current Price
H

ImmuCell Stock Fundamentals & Key Indicators

Market Cap
N/A
PE Ratio (TTM)
54.80
Dividend Yield
0.00%
EPS (TTM)
$0.21
Revenue (TTM)
$27.64B
Return On Equity (TTM)
5.74%
Profit Margin
-3.76%
Debt to Equity
0.24
Quarterly Earnings Growth YoY
133.33%

ImmuCell Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$7.63$10.36$7.19$8.04
Net Profit-$2.85$1.94$1.83$0.95
Net Profit Margin-37.35%18.73%25.45%11.82%
Income ChangeN/A168.07%-5.67%-48.09%

ImmuCell Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$18.57$17.47$26.49$27.64
Net Profit-$2.49-$5.77-$2.16-$1.04
Net Profit Margin-13.41%-33.03%-8.15%-3.76%
Income ChangeN/A-131.73%62.56%51.85%

ImmuCell Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets25.5930.0632.3430.79
Current Assets16.9415.0411.4714.07
Total Assets42.5345.143.8144.86
Non Current Liabilities11.513.1714.6211.41
Current Liabilities3.984.414.23.07
Total Liabilities15.4817.5818.8214.48
Shareholders' Equity27.0627.5224.9930.38

ImmuCell Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating2.480.36-4.67-1.54
Investing-1.21-0.46-1.89-3.96
Financing-1.212.881.751.11

About ImmuCell

ImmuCell Corp is an animal health biologics company focused on the development, manufacture, and commercialization of products intended to improve the survivability, health, and long-term performance of neonatal dairy and beef calves. Its product, First Defense, utilizes hyperimmunized bovine colostrum to provide pathogen-specific antibodies and other bioactive components. First Defense is designed to provide Immediate Immunity through orally delivered antibodies against the principal viral and bacterial causes of neonatal calf diarrhea (scours), including Escherichia coli (E.coli), bovine coronavirus, and bovine rotavirus. It has two operating segments: Scours and Mastitis. It derives the majority of the revenue from the Scours segment that consists of the First Defense product line.

ImmuCell Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$10.41
$11.43
+13.68%
Oct 2026
$9.63
$10.05
-0.40%
Sep 2026
$9.89
$10.09
+2.49%
Aug 2026
$11.06
$9.85
-11.55%
Jul 2026
$10.48
$11.13
+10.42%
Jun 2026
$9.71
$10.08
-0.40%
May 2026
$8.61
$10.12
+22.37%
Apr 2026
$6.37
$8.27
+30.75%
Mar 2026
$6.29
$6.33
-4.53%
Feb 2026
$6.12
$6.63
+7.20%
Jan 2026
$6.14
$6.18
+0.00%
Dec 2025
$4.76
$6.18
+26.90%

ImmuCell Share Price FAQs